Zafrens

Zafrens

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.zafrens.com

Last Round

Series A

Feb 4, 2025

Total Funding Raised

$60.16M

Company Overview

Zafrens is a life sciences company that develops innovative products to provide insights at the intersection of biology, chemistry, and engineering, utilizing advanced techniques to study cell interactions and leveraging curated data to enhance drug discovery through artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotech Equipment, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

drug discovery platformhigh-throughput screeningsingle-cell multi-omicsphenotypic screeningmulti-modal analysisfunctional genomicsHTSdrug discovery servicesCROnanofabricationAI drug discoverylab automationCAR-T optimizationsmall molecule screeninginternal therapeutics pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zafrens Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zafrens Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 4, 2025
Series ADec 11, 2023
SeedDec 30, 2021

Zafrens Investors

Notable investors and investment history

InvestorRounds
Iaso VenturesSeries A
KOFA HealthcareSeries A
BlueYard CapitalSeries A
FoundersX VenturesSeries A
Alix VenturesSeries A
Hawktail ManagementSeries A
imec.xpandSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 4, 2025

    $31M round with participation from BlueYard Capital and others.

Zafrens Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zafrens Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zafrens's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range30
Year Founded2022
Last FundingFeb 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.